Latest Biotech News

Moderna and Merck disclosed positive Phase 3 topline results for intismeran autogene, their individualized neoantigen cancer vaccine, in INTerpath-001 (NCT05933577). In a 1,137-participant study,...

Abcuro said it is adding $66 million to re-enter development in inclusion body myositis, a rare inflammatory disorder with no approved disease-modifying therapies. The company plans a new study...

Cityblock Health agreed to acquire Homeward Health and simultaneously raised $116 million in a Series E to expand its value-based care model into rural and Medicare Advantage populations. The...

A new industry analysis argues that pharma marketers need a ‘share-of-answer’ strategy before increasing AI ad budgets. The piece ties the shift to changes in how clinicians use AI tools during...

Cleveland Clinic reported that its AI scribe rollout improved clinician satisfaction and retention, according to research described in a new paper. With health systems under continuing workforce...

A multi-stakeholder consensus roadmap published in the British Journal of Cancer outlines how clinical trials for rare childhood central nervous system tumors could be redesigned to move faster...

A study in Cell Death Discovery reported that blocking glucosylceramide production kills cancer cells through lysosomal dysfunction rather than ceramide accumulation. The work points to an...

Researchers used AI to decode the DNA signature of a key genetic ‘on switch’ involved in turning genes on. By analyzing roughly 500,000 DNA sequences, the model identified the initiator in about...

A study in Pediatric Research examined whether the triglyceride–glucose (TyG) index, calculated from routine blood tests, is associated with elevated blood pressure in adolescents. The work...

A study highlighted how mouth bacteria could migrate into gastrointestinal compartments in certain cancers, raising the prospect of a microbiome-based diagnostic signal. Researchers at Yonsei...

Merck and Moderna announced positive Phase 3 results for intismeran (individualized neoantigen therapy) combined with pembrolizumab (Keytruda), reporting improved outcomes versus Keytruda alone in...

Abcuro secured $66 million to pursue a new development path in inclusion body myositis (IBM), a rare inflammatory disorder with no approved drugs. The company said it will use the capital to...

Cityblock Health agreed to acquire rural provider Homeward Health and also raised $116 million in a Series E round to broaden its value-based care model. The plan targets rural and Medicare...

A real-world analysis of Oregon’s regulated nonmedical psilocybin program reported broadly favorable experiences and a low rate of serious adverse reactions. The study, led by Todd Korthuis at...

Researchers at Yonsei University reported that bacteria typically found in the mouth can show increased overlap with fecal microbiomes in gastrointestinal cancer patients, raising the possibility...

A new study in Cell Death Discovery reported that blocking glucosylceramide production kills cancer cells through lysosomal dysfunction rather than ceramide buildup. The findings focus on how...

A multi-stakeholder consensus published in the British Journal of Cancer proposes a practical roadmap to improve clinical trial execution in rare childhood central nervous system tumors. The...

KAIST researchers identified a pathway to help electric-vehicle batteries charge faster without significant performance or lifespan losses by using a three-dimensional digital twin of a real...

Researchers reported an AI-derived identification of DNA “initiator” sequences that help turn genes on, detecting the initiator in roughly 60% of human genes after analyzing about 500,000 DNA...

A new Cochrane evidence and gap map found a striking imbalance in dengue prevention research: hundreds of primary studies exist, but the evidence most needed by health authorities remains...